Michael Weening - Feb 8, 2024 Form 4 Insider Report for CALIX, INC ((CALX))

Role
President & CEO, Director
Signature
/s/ Tom Gemetti as Attorney-in-Fact for Michael Weening
Stock symbol
(CALX)
Transactions as of
Feb 8, 2024
Transactions value $
$11,927
Form type
4
Date filed
2/12/2024, 06:12 PM
Previous filing
Nov 28, 2023
Next filing
Feb 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction (CALX) Common Stock Purchase $11.9K +341 +2.38% $34.98 14.7K Aug 14, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction (CALX) Stock Option (right to buy) Award $0 +54.5K $0.00 54.5K Feb 8, 2024 Common Stock 54.5K $51.55 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Calix, Inc. Amended and Restated Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of February 15, 2022 through August 14, 2023. This transaction is exempt under Rule 16b-3(c).
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on August 14, 2023, the last trading day of the purchase period.
F3 On February 9, 2023, the reporting person was awarded a performance-based nonqualified stock option grant covering 100,000 shares of common stock. On February 8, 2024, the Compensation Committee of Calix, Inc. determined that the performance criteria governing 54.5% of the grant had been achieved, resulting in a nonqualified stock option award of 54,500 shares of common stock for the reporting person. The nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on February 8, 2024; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from February 8, 2024.